- Poster presentation
- Open Access
Seroprevalence of hepatitis C virus markers in multi-transfused children with beta-thalassemia
BMC Infectious Diseases volume 12, Article number: P42 (2012)
To study the seroprevalence of hepatitis C virus in multi-transfused children with β-thalassemia and compared with non transfused children and healthy controls. β-thalassemic children fail to thrive, with growth and developmental retardation and suffer microcytic hypochromic anemia. Since regular blood transfusions are given to maintain haemoglobin at a safe level, these children are at a high risk of acquiring hepatitis C virus through transfusions.
Study group, consisted of children 2-13 years with β-thalassemia and received more than 5 transfusions. Matched control group consisted of 30 children with β-thalassemia and no transfusion. Control group, consisted of 30 normal healthy children serum samples from all three groups were tested for antibodies to hepatitis C virus using commercial ELISA kits.
Study showed 32% anti H hepatitis C virus positivity in multi-transfused and 0% in matched and healthy control groups. Hepatitis C virus infection showed a significant increase in relation to the number of transfusions received.
This observation is of great concern, as these children are at a risk of developing chronic hepatitis, cirrhosis and hepatocellular carcinoma. Since vaccination against hepatitis C virus is not available, highly sensitive and specific screening methods of donor blood in blood banks must be made mandatory.
About this article
Cite this article
Madhusudhan, K., Thyagarajan, S. Seroprevalence of hepatitis C virus markers in multi-transfused children with beta-thalassemia. BMC Infect Dis 12, P42 (2012). https://doi.org/10.1186/1471-2334-12-S1-P42
- Hepatocellular Carcinoma
- Chronic Hepatitis
- Healthy Control Group
- Safe Level
- Blood Bank